MN551 Unit 2 cell injury explanation example

Acetaminophen Overdose in a 19-Year-Old: Following One Metabolite From Glutathione Depletion to Centrilobular Necrosis

[Student Name]

Purdue University Global

MN551: Advanced Physiology and Pathophysiology

Unit 2 Assignment

[Instructor Name]

[Date]

Composite case written as a model document. No real patient, hospital or clinician is described.

The Case and the Question It Poses

A composite 19-year-old bakery apprentice weighing 65 kg took 20 extra-strength acetaminophen tablets, 10 g in total, after an argument at home. Twelve hours later she reports mild nausea and nothing else. Her vital signs are normal, her abdomen is soft, and her alanine aminotransferase (ALT) is 38 U/L. By hour 36 the ALT has reached 2,900 U/L, and by hour 72 the international normalized ratio (INR) is 3.1 and total bilirubin 4.2 mg/dL. The dose, roughly 154 mg/kg, sits above the 150 mg/kg range at which hepatotoxicity becomes likely after a single ingestion (Yoon et al., 2016).

The quiet first day is the finding this paper has to explain, because a mechanism that cannot account for a well-looking patient at hour 12 has not accounted for the injury. Her nausea is not evidence of liver injury; it reflects the drug's direct effect on the gut and the stress of the ingestion. Nothing in her early examination or chemistry distinguishes her from someone who took a harmless dose, and that sameness is the clinical danger the mechanism explains. The explanation below is organized by the question a reader would ask at each point on a band running from hour zero to hour 96.

Ordinary Handling: A Change in Proportions, Not a New Pathway

At a therapeutic dose, most acetaminophen is conjugated in the liver with glucuronide or sulfate and leaves in the urine as harmless, water-soluble products. A small share, in the range of 5 to 10 percent, is oxidized by cytochrome P450 enzymes, chiefly CYP2E1, to N-acetyl-p-benzoquinone imine (NAPQI), a reactive electrophile (Yoon et al., 2016). NAPQI never accumulates at ordinary doses, because hepatocyte glutathione binds it almost as fast as it forms and the conjugate is excreted.

An overdose does not open a new route. It changes the proportions among existing ones. As the sulfation pathway saturates and glucuronidation approaches capacity, a larger fraction of each hour's drug load reaches the oxidative route, and NAPQI production rises. Glutathione is consumed faster than the cell can resynthesize it. Injury begins when stores fall below roughly 30 percent of normal, because below that level NAPQI is no longer captured before it reaches cellular proteins (Hinson et al., 2010). The tablet count matters only because of what it does to this ratio, which is why the threshold is expressed in milligrams per kilogram rather than in pills.

Inside the Mitochondrion: From Protein Adducts to ATP Collapse

Once glutathione is exhausted, NAPQI binds covalently to cysteine residues on cellular proteins, and the adducts that matter most form on mitochondrial proteins. Adduct formation impairs the electron transport chain and generates superoxide, which reacts with nitric oxide to form peroxynitrite. This oxidant stress activates c-Jun N-terminal kinase (JNK) in the cytosol. Phosphorylated JNK translocates to the outer mitochondrial membrane, where it amplifies the oxidant stress that activated it, a loop that turns a limited injury into a self-sustaining one (Ramachandran & Jaeschke, 2019).

The decisive event is the opening of the mitochondrial permeability transition pore. When the pore opens, the inner membrane loses its potential, ATP synthesis stops, and the mitochondria swell. Endonucleases released from the intermembrane space fragment nuclear DNA. Without ATP, sodium-potassium pumps fail, sodium and water enter the cell, and the hepatocyte swells and ruptures. This is oncotic necrosis, not apoptosis. The caspase activation that defines apoptosis is minimal in this injury, and the energy collapse that ends the cell is inconsistent with the ATP-dependent steps apoptosis requires (Ramachandran & Jaeschke, 2019).

The line between reversible and irreversible injury falls at the permeability transition. Before the pore opens, a hepatocyte with adducts and early swelling can still recover if glutathione is restored and oxidant stress subsides. After it opens across enough mitochondria, the cell cannot regenerate the ATP needed to restore ion gradients, and death follows. The latent phase is simply the time these events take: hours of glutathione depletion, adduct formation and JNK amplification pass before enough cells rupture to release measurable enzyme.

Why Zone 3

The injury is not scattered through the liver. Hepatocytes around the central vein, zone 3 of the acinus, die first and in the greatest numbers. Two gradients explain the pattern. CYP2E1 is concentrated in zone 3, so NAPQI is generated there at the highest rate, and glutathione content is lower there than in periportal cells. Blood also reaches zone 3 last, after periportal cells have extracted much of its oxygen, so these hepatocytes carry the least reserve when their mitochondria begin to fail (Rogers, 2023). Centrilobular necrosis, often recited as a textbook phrase, is the predictable result of generating the most toxin where the defenses and the oxygen are thinnest.

The same gradients explain what survives. Periportal hepatocytes in zone 1 receive oxygen-rich blood first, carry more glutathione and less CYP2E1, and are usually spared even in severe injury. Those surviving cells matter for the course of the case, because the liver regenerates from them once NAPQI production ends. A biopsy taken at hour 48 would therefore show a band of necrosis around each central vein with a rim of intact cells near the portal tracts, and the pattern itself would point back to a toxin activated by a zone 3 enzyme rather than to an ischemic or viral cause spread across the acinus. Sterile inflammation follows the necrosis: damage-associated molecules released from ruptured cells recruit neutrophils and macrophages, which clear debris and may extend injury at the margins, although most of the cell death is complete before these cells arrive (Ramachandran & Jaeschke, 2019).

Placing the Numbers on the Band

Each laboratory value belongs at the hour its cause begins. ALT is normal at hour 12 because too few hepatocytes have ruptured to release it. It rises after the first day as necrosis spreads and peaks between hours 72 and 96, which is why the 2,900 U/L at hour 36 is still climbing. The INR follows a different clock. Clotting factor VII has a half-life of about 4 to 6 hours, so when synthesis fails its level falls within a day, and the INR of 3.1 at hour 72 reflects lost hepatic production rather than damage in a general sense. Bilirubin arrives last, at 4.2 mg/dL, because conjugation and excretion capacity must be widely lost before it accumulates.

The chain also shows where a known antidote acts. N-acetylcysteine supplies cysteine for glutathione synthesis, restoring the capacity to capture NAPQI, which is why its effect is greatest before glutathione is exhausted and the permeability transition has occurred (Hinson et al., 2010). Stated as mechanism, this is the same threshold that began the injury, now approached from the other side. The same logic explains why the calm first day is the most important window in the case: the cells that will die at hour 48 are still recoverable at hour 12, but nothing in the patient's appearance says so.

References

Hinson, J. A., Roberts, D. W., & James, L. P. (2010). Mechanisms of acetaminophen-induced liver necrosis. Handbook of Experimental Pharmacology, 196, 369-405. https://doi.org/10.1007/978-3-642-00663-0_12

Ramachandran, A., & Jaeschke, H. (2019). Acetaminophen hepatotoxicity. Seminars in Liver Disease, 39(2), 221-234. https://doi.org/10.1055/s-0039-1679919

Rogers, J. L. (Ed.). (2023). McCance and Huether's pathophysiology: The biologic basis for disease in adults and children (9th ed.). Elsevier.

Yoon, E., Babar, A., Choudhary, M., Kutner, M., & Pyrsopoulos, N. (2016). Acetaminophen-induced hepatotoxicity: A comprehensive update. Journal of Clinical and Translational Hepatology, 4(2), 131-142. https://doi.org/10.14218/JCTH.2015.00052